Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasey L Rivas

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Trends in Pharmacological Sciences|January 15, 2008
Novel paradigms for drug discovery: computational multitarget screeningEkachai Jenwitheesuk, Jeremy A Horst, Kasey L Rivas, et al.
Journal of Medicinal Chemistry|March 5, 2019
Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyWenlin Huang, Matthew A Hulverson, Ryan Choi, et al.
International Journal for Parasitology|October 13, 2016
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapyKayode K Ojo, Sriveny Dangoudoubiyam, Shiv K Verma, et al.
The Journal of Infectious Diseases|December 8, 2016
Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for CryptosporidiosisDeborah A Schaefer, Dana P Betzer, Kylie D Smith, et al.
The Journal of Infectious Diseases|November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against ToxoplasmosisMatthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferaseWesley C Van Voorhis, Kasey L Rivas, Pravin Bendale, et al.
The Journal of Infectious Diseases|October 15, 2013
A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validationKayode K Ojo, Richard T Eastman, Ramasubbarao Vidadala, et al.
The Journal of Infectious Diseases|March 23, 2017
Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyMatthew A Hulverson, Sumiti Vinayak, Ryan Choi, et al.
International Journal for Parasitology. Drugs and Drug Resistance|March 5, 2018
Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoitesRoberto Sánchez-Sánchez, Ignacio Ferre, Michela Re, et al.
Plos One|March 3, 2016
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active CompoundsGregory J Crowther, Heidi K Hillesland, Katelyn R Keyloun, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Trends in Pharmacological Sciences|January 15, 2008
Novel paradigms for drug discovery: computational multitarget screeningEkachai Jenwitheesuk, Jeremy A Horst, Kasey L Rivas, et al.
Journal of Medicinal Chemistry|March 5, 2019
Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyWenlin Huang, Matthew A Hulverson, Ryan Choi, et al.
International Journal for Parasitology|October 13, 2016
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapyKayode K Ojo, Sriveny Dangoudoubiyam, Shiv K Verma, et al.
The Journal of Infectious Diseases|December 8, 2016
Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for CryptosporidiosisDeborah A Schaefer, Dana P Betzer, Kylie D Smith, et al.
The Journal of Infectious Diseases|November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against ToxoplasmosisMatthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferaseWesley C Van Voorhis, Kasey L Rivas, Pravin Bendale, et al.
The Journal of Infectious Diseases|October 15, 2013
A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validationKayode K Ojo, Richard T Eastman, Ramasubbarao Vidadala, et al.
The Journal of Infectious Diseases|March 23, 2017
Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyMatthew A Hulverson, Sumiti Vinayak, Ryan Choi, et al.
International Journal for Parasitology. Drugs and Drug Resistance|March 5, 2018
Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoitesRoberto Sánchez-Sánchez, Ignacio Ferre, Michela Re, et al.
Plos One|March 3, 2016
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active CompoundsGregory J Crowther, Heidi K Hillesland, Katelyn R Keyloun, et al.
Pageof 2